Logo image of ALMIB.PA

AMOEBA SAS (ALMIB.PA) Stock Fundamental Analysis

EPA:ALMIB - Euronext Paris - Matif - FR0011051598 - Common Stock - Currency: EUR

1.002  -0.06 (-5.47%)

Fundamental Rating

0

Taking everything into account, ALMIB scores 0 out of 10 in our fundamental rating. ALMIB was compared to 69 industry peers in the Chemicals industry. Both the profitability and financial health of ALMIB have multiple concerns. ALMIB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALMIB has reported negative net income.
In the past year ALMIB has reported a negative cash flow from operations.
ALMIB had negative earnings in each of the past 5 years.
ALMIB had a negative operating cash flow in each of the past 5 years.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

ALMIB has a Return On Assets of -116.64%. This is amonst the worse of the industry: ALMIB underperforms 95.65% of its industry peers.
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROIC N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

1.3 Margins

ALMIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALMIB has more shares outstanding
Compared to 5 years ago, ALMIB has more shares outstanding
ALMIB has a worse debt/assets ratio than last year.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALMIB has an Altman-Z score of -8.11. This is a bad value and indicates that ALMIB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.11, ALMIB is doing worse than 91.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.11
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ALMIB has a Current Ratio of 0.42. This is a bad value and indicates that ALMIB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALMIB (0.42) is worse than 94.20% of its industry peers.
A Quick Ratio of 0.37 indicates that ALMIB may have some problems paying its short term obligations.
ALMIB's Quick ratio of 0.37 is on the low side compared to the rest of the industry. ALMIB is outperformed by 92.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.37
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ALMIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.20%, which is quite impressive.
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.85%
EPS Next 2Y-2.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2025 2026 2027 5M 10M 15M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALMIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

ALMIB's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.53%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

ALMIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMOEBA SAS

EPA:ALMIB (6/19/2025, 7:00:00 PM)

1.002

-0.06 (-5.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-26 2025-03-26
Earnings (Next)10-01 2025-10-01
Inst Owners0.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.76M
Analysts89.09
Price Target1.67 (66.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)27.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -116.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 267.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.37
Altman-Z -8.11
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)289.55%
Cap/Depr(5y)177.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.72%
EPS Next Y-17.85%
EPS Next 2Y-2.53%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.03%
EBIT Next 3Y37.15%
EBIT Next 5YN/A
FCF growth 1Y50%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.18%
OCF growth 3YN/A
OCF growth 5YN/A